title: Severe septicaemia in a patient with polychondritis and Sweet's syndrome after initiation of treatment with infliximab.
authors.affiliation: University of Erlangen-Nuremberg, Department of Internal Medicine III and Institute for Clinical Immunology, Krankenhausstrasse 12, 91054 Erlangen, Germany.
authors.forename: F G
authors.initials: FG
authors.lastname: Matzkies
authors.forename: B
authors.initials: B
authors.lastname: Manger
authors.forename: M
authors.initials: M
authors.lastname: Schmitt-Haendle
authors.forename: T
authors.initials: T
authors.lastname: Nagel
authors.forename: H-G
authors.initials: HG
authors.lastname: Kraetsch
authors.forename: J R
authors.initials: JR
authors.lastname: Kalden
authors.forename: H
authors.initials: H
authors.lastname: Schulze-Koops
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D003922:Diabetes Mellitus, Type 1 / Q000150:complications / Q000276:immunology; D017809:Fatal Outcome; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D011081:Polychondritis, Relapsing / Q000150:complications* / Q000276:immunology; D018805:Sepsis / Q000209:etiology* / Q000276:immunology; D016463:Sweet Syndrome / Q000150:complications* / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D000069285:Infliximab; D001379:Azathioprine